胆固醇性肝病的治疗方法:氧化通路的作用
Naser-Aldin Lashgari1,2, Danial Khayatan1,2, Nazanin Momeni Roudsari1,2
1Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St., Tehran, Iran, P. O. Box: 19419-33111.
Naunyn-Schmiedeberg's archives of pharmacology
|September 22, 2023
概括
过多的氧化 (NO) 会使胆固醇性肝脏疾病恶化. 自然产品和药物可以通过向关键炎症途径来减少NO的产生,为胆固醇病提供了潜在的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆固醇,胆汁流失,导致疲劳,和黄.
- 中性粒细胞和氧化 (NO) 是胆固醇性肝病的关键媒介.
- 过度的NO,由诱导性氧化合成酶 (iNOS) 生产,加剧炎症和细胞损伤.
研究的目的:
- 审查NO在胆固醇性肝病中的作用.
- 总结关于胆酸信号传递和胆固醇中性粒细胞招募的数据.
- 确定调节NO生产和相关途径的治疗剂.
主要方法:
- 临床,体外和体内研究的文献综述.
- 从PubMed,谷歌学者,斯科普斯和科克兰图书馆 (2000-2021) 收集的数据.
- 对NO生产,iNOS表达和相关信号通路 (NF-κB,JAK/STAT,TLR4) 的分析.
主要成果:
- 几种天然产品 (贝卡林,黄素,白醇,烯) 和药物 (乌尔索多西胆酸,德克萨米他,罗斯瓦斯塔丁,氨酸,西尔德纳菲尔) 减弱了NO的产生.
- 这些药物主要通过调节NF-κB,JAK/STAT和TLR4信号通路而起作用.
- 抑制NO和相关途径成为一种潜在的治疗方法.
结论:
- 氧化在胆固醇性肝病中起着重要的,尽管复杂的作用.
- 准NO生产及其相关的炎症途径是一个有希望的治疗策略.
- 对NO向疗法的进一步研究可能会导致针对胆固醇病的新治疗方法.
相关概念视频
Nitric Oxide Signaling Pathway
5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
Antianginal Drugs: Nitrates and β-Blockers
628
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
628
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Antihypertensive Drugs: Vasodilators
556
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
556
Angina IV: Management
11
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Angina V: Nursing Management
18
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
18


